North America Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Indication (Anxiety and Depression) By Drugs, By Distribution Channel, By Country and Growth Forecast, 2024 - 2031

The North America Anxiety Disorders And Depression Treatment Market would witness market growth of 2.9% CAGR during the forecast period (2024-2031).

The US market dominated the North America Anxiety Disorders And Depression Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $4,033.9 million by 2031. The Canada market is experiencing a CAGR of 4.9% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 4.3% during (2024 - 2031).

Depression and anxiety disorders are prevalent mental health conditions that can have a substantial effect on an individual’s quality of life. Treatment for these conditions involves a range of approaches designed to alleviate symptoms, improve functioning, and enhance overall wellbeing.

Additionally, a variety of approaches are employed to treat anxiety disorders and depression, each of which is customized to meet the requirements of the individual. Each application is crucial in managing symptoms, improving quality of life, and supporting long-term mental health. In primary care settings, routine screenings for anxiety and depression are integrated into general health check-ups.

The rising number of depression cases in the USA leads to a higher demand for antidepressants. This surge boosts the pharmaceutical market as drug manufacturers develop and distribute a broader range of antidepressant medications to address different types of depression. In 2020, 18.4% of U.S. adults reported having ever been diagnosed with depression, according to the Centers for Disease Control and Prevention. State-level age-standardized estimates varied from 12.7% in Hawaii to 27.5% in West Virginia.

Free Valuable Insights: The Anxiety Disorders And Depression Treatment Market is Predict to reach USD 15.7 Billion by 2031, at a CAGR of 3.5%

Based on Indication, the market is segmented into Anxiety and Depression. Based on Drugs, the market is segmented into Antidepressants, Anxiolytics, Anticonvulsants, Noradrenergic Agents, and Atypical Antipsychotics. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Pfizer Inc.
• GlaxoSmithKline PLC (GSK)
• Merck & Co., Inc.
• Eli Lilly And Company
• AstraZeneca PLC
• Bristol-Myers Squibb Company
• Johnson & Johnson
• AbbVie Inc.
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited

North America Anxiety Disorders And Depression Treatment Market Report Segmentation

By Indication

• Anxiety
• Depression

By Drugs

• Antidepressants
• Anxiolytics
• Anticonvulsants
• Noradrenergic Agents
• Atypical Antipsychotics

By Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Anxiety Disorders And Depression Treatment Market, by Indication
1.4.2 North America Anxiety Disorders And Depression Treatment Market, by Drugs
1.4.3 North America Anxiety Disorders And Depression Treatment Market, by Distribution Channel
1.4.4 North America Anxiety Disorders And Depression Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. North America Anxiety Disorders And Depression Treatment Market by Indication
4.1 North America Anxiety Market by Country
4.2 North America Depression Market by Country

Chapter 5. North America Anxiety Disorders And Depression Treatment Market by Drugs
5.1 North America Antidepressants Market by Country
5.2 North America Anxiolytics Market by Country
5.3 North America Anticonvulsants Market by Country
5.4 North America Noradrenergic Agents Market by Country
5.5 North America Atypical Antipsychotics Market by Country

Chapter 6. North America Anxiety Disorders And Depression Treatment Market by Distribution Channel
6.1 North America Retail Pharmacies Market by Country
6.2 North America Hospital Pharmacies Market by Country
6.3 North America Online Pharmacies Market by Country

Chapter 7. North America Anxiety Disorders And Depression Treatment Market by Country
7.1 US Anxiety Disorders And Depression Treatment Market
7.1.1 US Anxiety Disorders And Depression Treatment Market by Indication
7.1.2 US Anxiety Disorders And Depression Treatment Market by Drugs
7.1.3 US Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.2 Canada Anxiety Disorders And Depression Treatment Market
7.2.1 Canada Anxiety Disorders And Depression Treatment Market by Indication
7.2.2 Canada Anxiety Disorders And Depression Treatment Market by Drugs
7.2.3 Canada Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.3 Mexico Anxiety Disorders And Depression Treatment Market
7.3.1 Mexico Anxiety Disorders And Depression Treatment Market by Indication
7.3.2 Mexico Anxiety Disorders And Depression Treatment Market by Drugs
7.3.3 Mexico Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.4 Rest of North America Anxiety Disorders And Depression Treatment Market
7.4.1 Rest of North America Anxiety Disorders And Depression Treatment Market by Indication
7.4.2 Rest of North America Anxiety Disorders And Depression Treatment Market by Drugs
7.4.3 Rest of North America Anxiety Disorders And Depression Treatment Market by Distribution Channel

Chapter 8. Company Profiles
8.1 Pfizer, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 GlaxoSmithKline PLC (GSK)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Merck & Co., Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Eli Lilly And Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 AstraZeneca PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Bristol-Myers Squibb Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Johnson & Johnson
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental & Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 AbbVie, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Sanofi S.A.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Takeda Pharmaceutical Company Limited
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis

TABLE 1 North America Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 2 North America Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 3 North America Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 4 North America Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 5 North America Anxiety Market by Country, 2020 - 2023, USD Million
TABLE 6 North America Anxiety Market by Country, 2024 - 2031, USD Million
TABLE 7 North America Depression Market by Country, 2020 - 2023, USD Million
TABLE 8 North America Depression Market by Country, 2024 - 2031, USD Million
TABLE 9 North America Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 10 North America Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 11 North America Antidepressants Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Antidepressants Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Anxiolytics Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Anxiolytics Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Anticonvulsants Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Anticonvulsants Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Noradrenergic Agents Market by Country, 2020 - 2023, USD Million
TABLE 18 North America Noradrenergic Agents Market by Country, 2024 - 2031, USD Million
TABLE 19 North America Atypical Antipsychotics Market by Country, 2020 - 2023, USD Million
TABLE 20 North America Atypical Antipsychotics Market by Country, 2024 - 2031, USD Million
TABLE 21 North America Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 22 North America Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 23 North America Retail Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Retail Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 26 North America Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 27 North America Online Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Online Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Anxiety Disorders And Depression Treatment Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Anxiety Disorders And Depression Treatment Market by Country, 2024 - 2031, USD Million
TABLE 31 US Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 32 US Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 33 US Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 34 US Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 35 US Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 36 US Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 37 US Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 38 US Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 39 Canada Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 40 Canada Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 41 Canada Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 42 Canada Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 43 Canada Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 44 Canada Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 45 Canada Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 46 Canada Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 47 Mexico Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 48 Mexico Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 49 Mexico Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 50 Mexico Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 51 Mexico Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 52 Mexico Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 53 Mexico Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 54 Mexico Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 55 Rest of North America Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 56 Rest of North America Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 57 Rest of North America Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 58 Rest of North America Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 59 Rest of North America Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 60 Rest of North America Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 61 Rest of North America Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 62 Rest of North America Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 63 Key Information – Pfizer, Inc.
TABLE 64 Key Information – GlaxoSmithKline PLC
TABLE 65 Key Information - Merck & Co., Inc.
TABLE 66 Key Information – Eli Lilly And Company
TABLE 67 Key Information – AstraZeneca PLC
TABLE 68 Key Information – Bristol-Myers Squibb Company
TABLE 69 Key Information – Johnson & Johnson
TABLE 70 Key information – AbbVie, Inc.
TABLE 71 Key Information – Sanofi S.A.
TABLE 72 Key Information – Takeda Pharmaceutical Company Limited

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Anxiety Disorders And Depression Treatment Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Anxiety Disorders And Depression Treatment Market
FIG 4 Porter’s Five Forces Analysis – Anxiety Disorders And Depression Treatment Market
FIG 5 North America Anxiety Disorders And Depression Treatment Market share by Indication, 2023
FIG 6 North America Anxiety Disorders And Depression Treatment Market share by Indication, 2031
FIG 7 North America Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2031, USD Million
FIG 8 North America Anxiety Disorders And Depression Treatment Market share by Drugs, 2023
FIG 9 North America Anxiety Disorders And Depression Treatment Market share by Drugs, 2031
FIG 10 North America Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2031, USD Million
FIG 11 North America Anxiety Disorders And Depression Treatment Market share by Distribution Channel, 2023
FIG 12 North America Anxiety Disorders And Depression Treatment Market share by Distribution Channel, 2031
FIG 13 North America Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2031, USD Million
FIG 14 North America Anxiety Disorders And Depression Treatment Market share by Country, 2023
FIG 15 North America Anxiety Disorders And Depression Treatment Market share by Country, 2031
FIG 16 North America Anxiety Disorders And Depression Treatment Market by Country, 2020 - 2031, USD Million
FIG 17 SWOT Analysis: Pfizer, Inc.
FIG 18 SWOT Analysis: GlaxoSmithKline PLC
FIG 19 SWOT Analysis: Merck & Co., Inc.
FIG 20 Swot Analysis: Eli Lilly And Company
FIG 21 SWOT Analysis: AstraZeneca PLC
FIG 22 SWOT Analysis: Bristol-Myers Squibb Company
FIG 23 SWOT Analysis: Johnson & Johnson
FIG 24 Swot Analysis: AbbVie, Inc.
FIG 25 Swot Analysis: Sanofi S.A.
FIG 26 SWOT Analysis:Takeda Pharmaceutical Company Limited